We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.25 | -3.45% | 7.00 | 6.80 | 7.20 | 7.25 | 7.00 | 7.25 | 1,627,265 | 08:40:37 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -6.86 | 42.02M |
From Apr 2019 to Apr 2024
TIDMKMK
RNS Number : 7552K
Kromek Group PLC
18 December 2018
18 December 2018
Kromek Group plc
("Kromek" or the "Company")
Notice of Results
Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security and civil nuclear markets, will be announcing its interim results for the six months ended 31 October 2018 on Monday 14 January 2019.
The Company will be hosting a presentation to analysts at 9.00am GMT, on the day, at the offices of Luther Pendragon, 48 Gracechurch Street, London, EC3V 0EJ.
For further information, please contact:
Kromek Group plc Arnab Basu, CEO Derek Bulmer, CFO +44 (0)1740 626 060 Cenkos Securities plc (Nominated Adviser and Joint Broker) Max Hartley (NOMAD) Julian Morse (Sales) +44 (0)20 7397 8900 Cantor Fitzgerald Europe (Joint Broker) Philip Davies Will Goode +44 (0)20 7894 7000 Luther Pendragon Ltd (PR) Harry Chathli Claire Norbury Alexis Gore +44 (0)20 7618 9100
About Kromek Group plc
Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NORFFIEDWFASEFE
(END) Dow Jones Newswires
December 18, 2018 02:00 ET (07:00 GMT)
1 Year Kromek Chart |
1 Month Kromek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
